Back to Search
Start Over
N-3 polyunsaturated fatty acids: Prophylaxis and symptomatic therapy for oxaliplatin-induced peripheral neuropathy—A randomized, double-blind placebo controlled trial
- Source :
- Journal of Clinical Oncology. 33:e14504-e14504
- Publication Year :
- 2015
- Publisher :
- American Society of Clinical Oncology (ASCO), 2015.
-
Abstract
- e14504 Background: Oxaliplatin induced peripheral neuropathy (OXIPN) is the major dose-limiting side effect of oxaliplatin. N-3 PUFAs have known neuroprotective property. This study was a randomize...
- Subjects :
- chemistry.chemical_classification
Cancer Research
medicine.medical_specialty
Side effect
business.industry
Placebo-controlled study
medicine.disease
Neuroprotection
Gastroenterology
digestive system diseases
Oxaliplatin
Surgery
Double blind
stomatognathic diseases
Peripheral neuropathy
Oncology
chemistry
health services administration
Internal medicine
medicine
business
therapeutics
neoplasms
medicine.drug
Polyunsaturated fatty acid
Subjects
Details
- ISSN :
- 15277755 and 0732183X
- Volume :
- 33
- Database :
- OpenAIRE
- Journal :
- Journal of Clinical Oncology
- Accession number :
- edsair.doi...........68847059e7044acadc9c4079b86aa021